Nothing said here yet.
to join the conversation.
JBT Marel (JBTM) has caught investor attention after a year of mixed share performance, with the stock down about 28% year to date and roughly 16% over the past year.
JBT Marel has seen its share price fall sharply this year, and that kind of slide naturally puts the focus on whether the current valuation is still backed by the company’s earnings power.
Over the past six months, JBT Marel’s stock price fell to $105.19. Shareholders have lost 19.2% of their capital, which is disappointing considering the S&P 500 has climbed by 11.2%.
As the craze of earnings season draws to a close, here’s a look back at some of the most exciting (and some less so) results from Q2. Today, we are looking at general industrial machinery stocks, starting with JBT Marel (NYSE:JBTM).
On August 3, JBT Marel Corporation (NYSE:JBTM) reported second-quarter 2026 results that read as two different companies stapled together. Orders topped $1 billion, pushing the book-to-bill ratio to 1.05x and lifting backlog to $1.54 billion.
Investment management company First Pacific Advisors recently released its “FPA Queens Road Small Cap Value Fund” second-quarter 2026 investor letter. A copy of the letter can be downloaded here.
JBT Marel Corporation recently reported past second-quarter 2026 results showing higher sales of US$981 million and net income of US$28 million, updated its 2026 guidance including expected revenue of US$3.99 billion to US$4.07 billion and GAAP diluted EPS of…
JBT Marel’s second quarter saw solid revenue growth driven by resilient demand in both the Protein Solutions and Prepared Food and Beverage segments.